Viewing Study NCT04275518


Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2026-03-03 @ 6:45 PM
Study NCT ID: NCT04275518
Status: RECRUITING
Last Update Posted: 2024-10-15
First Post: 2020-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module